A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration

Abstract

Background A major challenge for any glaucoma implant is their ability to provide long-term intraocular pressure lowering efficacy. The formation of a low-permeability fibrous capsule around the device often leads to obstructed drainage channels, which may impair the drainage function of devices. These foreign body-related limitations point to the need to develop biologically inert biomaterials to improve performance in reaching long-term intraocular pressure reduction. The aim of this study was to evaluate in vivo (in rabbits) the ocular biocompatibility and tissue integration of a novel suprachoroidal microinvasive glaucoma implant, MINIject™ (iSTAR Medical, Wavre, Belgium). Results In two rabbit studies, no biocompatibility issue was induced by the suprachoroidal, ab-externo implantation of the MINIject™ device. Clinical evaluation throughout the 6 post-operative months between the sham and test groups were similar, suggesting most reactions were related to the ab-externo surgical technique used for rabbits, rather than the implant material itself. Histological analysis of ocular tissues at post-operative months 1, 3 and 6 revealed that the implant was well-tolerated and induced only minimal fibroplasia and thus minimal encapsulation around the implant. The microporous structure of the device became rapidly colonized by cells, mostly by macrophages through cell migration, which do not, by their nature, impede the flow of aqueous humor through the device. Time-course analysis showed that once established, pore colonization was stable over time. No fibrosis nor dense connective tissue development were observed within any implant at any time point. The presence of pore colonization may be the process by which encapsulation around the implant is minimized, thus preserving the permeability of the surrounding tissues. No degradation nor structural changes of the implant occurred during the course of both studies. Conclusions The novel MINIject™ microinvasive glaucoma implant was well-tolerated in ocular tissues of rabbits, with observance of biointegration, and no biocompatibility issues. Minimal fibrous encapsulation and stable cellular pore colonization provided evidence of preserved drainage properties over time, suggesting that the implant may produce a long-term ability to enhance aqueous outflow.

Poly-ε-caprolactone/Whitlockite Electrospun Bionic Membrane with an Osteogenic–Angiogenic Coupling Effect for Periosteal Regeneration

“…To further verify the angiogenic ability of the PCL/WH nanocomposite fiber membrane, the material was implanted into SD rats to verify its angiogenic ability in vivo. 29 All in vivo experiments in this study were approved by the Animal Care and Use Committees of the Wuhan University of Technology. The rats in this study were 200−250 g SD male rats (Lab Animal Research Center, Hubei, China).…”

Clinical and Optical Coherence Tomography Evidence of Aqueous Humor Flow from the Suprachoroidal Space to Conjunctival Lymphatics

“…Its implantation may result in a high incidence of sudden IOP peaks with a low success rate [ 55 ]. Several other devices have been proposed but are still under study [ 56 , 57 ].…”

Sustainable Antibacterial Surgical Suture Using a Facile Scalable Silk-Fibroin-Based Berberine Loading System

“…All animal experiments were conducted in accordance with the “Guiding Principles for the Care and Use of Laboratory Animals”. All animals were free to have water and food …”